The New Player in the CBD Beverage Space


Ryan Allway

November 5th, 2018

Exclusive, News


Cannabis based beverages have been making headlines in the industry lately. There is, of course, Constellation Brands’ major investment in Canopy Growth, a marriage of alcohol and cannabis giants. On a smaller scale, New Age Beverages Corp. recently announced its upcoming debut of a CBD-infused line of drinks. The announced plan triggered a run on the company’s stock. Over the course of three days (9/19-9/21) the price ran from $2.81 to a high of $8.86 before settling to $6.10 entering the weekend.

The Alkaline Water Company (TSXV: WTER) (OTCQB: WTER) came out with two announcements heralding its entry into the cannabis beverage space. A88 Infused Beverages Division, Inc., (A88 Infused) a wholly owned subsidiary of The Alkaline Water Company Inc., secured a deal with American Nutritional Products to manufacture and package the new product lines out of ANP’s Nevada facility. Considering Alkaline Water’s extensive distribution footprint, proven marketing strategies, and skyrocketing revenues, these developments could add significantly to the company’s prospects over the coming quarters.

CBD and More

Alkaline Water’s national success with its flagship product, Alkaline88®, makes A88 Infused the next logical step in expanding the company’s national footprint. The company is developing a line of enhanced products using the same proprietary Electrochemically Activated Water (ECA) system it has employed to create its signature 8.8 pH Alkaline88® without the use of any chemicals.

Four new product categories are already in various stages of development and will soon be available in markets nationwide and in Canada. All four have been developed based on current consumer demand and market potential for enhanced and functional beverages. A88 Infused is uniquely positioned to capitalize on this growing trend in the enhanced beverage space with the following products:

Hemp-derived CBD infused Alkaline88® water

CBD (cannabidiol) products are gaining momentum in the health and wellness world, with some scientific studies confirming it may help treat a variety of ailments like chronic pain and anxiety. Further research is being done, but there are also promising indications that CBD may be helpful in treating many other conditions such as depression, cancer and cancer treatment side effects, seizures related to neurological disorders, and heart health or high blood pressure issues to name a few. Consumer interest in CBD has risen to all-time highs as researchers continue to explore the potential medical & health benefits of cannabidiol. The company’s hemp-derived CBD infused Alkaline88® water will initially be available in the 500 ml size with a dosage of 10 mg of CBD per bottle.

Naturally Flavored Alkaline88® water

Naturally flavored waters have gained popularity with many U.S. consumers as a healthy alternative to soft drinks, and they contain less sugar and calories compared to carbonated drinks and juices. Growth rates in the essence water segment have accelerated over the past three years and is expected to double to $118 million in sales by 2021 and Naturally Flavored Alkaline88® water is poised to be part of this growing trend.

Natural Sparkling Alkaline88® water

While sales of sweetened beverages, like soda, declined by more than 8 percent by volume from 2011 to 2016, carbonated water grew by 70.4 percent.  Using its unique technology, Alkaline88® is bringing the first natural sparkling alkaline water to the market in the coming months with its Natural Sparkling Alkaline88® Water products.

Alkaline88® infused with Natural Vitamins and Minerals

Consumer demand for enhanced and functional beverages is at an all-time high and Alkaline88® is positioning itself to capture a major share of this new market.  The company has been exploring various water-soluble plant-derived vitamins and minerals to enhance its Alkaline88® Natural Vitamins and Minerals Water line. The company’s primary focus has been towards natural vitamin infusion combinations that support energy and offer the benefits of vitamin B-12. Alkaline88®’s commitment is to provide even more healthful beverage products while expanding on the previous success of their premier product, Alkaline88®.

State of the Art Facility

Alkaline Water’s co-packing and development agreement with ANP gives the company a quick path to market with plenty of room for growth. ANP’s facility is FDA registered, cGMP compliant, and has been certified by both the International Center for Cannabis Therapy and the National Sanitation Foundation. Basically, products made there can safely and legally be distributed throughout North America.

Additionally, the ANP team has years of experience in nutritional product development and formulation that should add quality and efficiency to the new infused beverage division’s efforts. ANP’s history with cannabinoid and other plant extraction techniques, when combined with Alkaline’s chemical-free ECA water technology, should make for a formidable entrant into the enhanced and infused water market. Alkaline hopes to launch several new infused products by the end of 2018.

Looking Back, and Ahead

Alkaline Water’s revenue growth has been impressive. Between 2014 and 2018, the company’s fiscal year end revenues have grow from $600,000 to almost $20 million. The company is projecting $40 million by the end of fiscal year 2019. The company has averaged 435 percent growth since 2014 and is projecting a 102 percent year over year increase in 2018.

The addition of A88 Infused and the variety of high-value products planned there could accelerate Alkaline’s growth significantly. The company is tapping into the highest growth sectors of North America’s beverage market with the flavored, enhanced, and sparkling water offerings. As for CBD beverages, the category is in its infancy. Judging from the investments made in the space, however, it could be the biggest growth factor of all. Stay tuned for further developments.

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://www.cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading